Related Experiment Video
Updated: Nov 3, 2025
13:12
Quantitative Analyses of all Influenza Type A Viral Hemagglutinins and Neuraminidases using Universal Antibodies in Simple Slot Blot Assays
Published on: April 4, 2011
18.5K
Targeting Antigens for Universal Influenza Vaccine Development
Quyen-Thi Nguyen1, Young-Ki Choi1,2
1College of Medicine and Medical Research Institute, Chungbuk National University, Cheongju 28644, Korea.
Viruses
|June 2, 2021
Summary
Developing a universal influenza vaccine (UIV) is crucial for protection against diverse flu strains. This review examines key antigens like hemagglutinin and neuraminidase for effective UIV strategies.
Area of Science:
- Virology
- Immunology
- Vaccinology
Background:
- Seasonal influenza vaccines offer limited protection due to rapid viral evolution (antigenic drift and shift).
- Current vaccines require annual updates, necessitating continuous reformulation and revaccination efforts.
- A universal influenza vaccine (UIV) is needed for sustained protection against all influenza strains, including pandemic threats.
Purpose of the Study:
- To review current strategies and perspectives on universal influenza vaccine (UIV) development.
- To evaluate the suitability of various target antigens for eliciting broad immune responses.
- To discuss the advantages and limitations of different antigen targets for UIVs.
Main Methods:
- Literature review of current research on universal influenza vaccine development.
- Analysis of antigen selection strategies for inducing cross-reactive immunity.
- Evaluation of immune responses generated by different antigen candidates.
Main Results:
- No single antigen strategy currently guarantees broad protection against divergent influenza strains.
- Hemagglutinin, neuraminidase, matrix proteins, and internal proteins are explored as UIV targets.
- Each antigen type presents unique advantages and limitations in generating effective, cross-reactive immunity.
Conclusions:
- Optimizing antigen selection is critical for developing a successful universal influenza vaccine.
- Further research is needed to overcome the limitations of current antigen strategies.
- A UIV holds significant potential for global public health by providing long-term influenza protection.
